NAYA BIOSCIENCES INC (NAYA) Fundamental Analysis & Valuation
NASDAQ:NAYA • US44984F4019
Current stock price
2.2 USD
+0.17 (+8.37%)
At close:
2.34 USD
+0.14 (+6.36%)
After Hours:
This NAYA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. NAYA Profitability Analysis
1.1 Basic Checks
- In the past year NAYA has reported negative net income.
- NAYA had a negative operating cash flow in the past year.
- NAYA had negative earnings in each of the past 5 years.
- In the past 5 years NAYA reported 4 times negative operating cash flow.
1.2 Ratios
- NAYA's Return On Assets of -43.87% is on the low side compared to the rest of the industry. NAYA is outperformed by 64.21% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -43.87% | ||
| ROE | N/A | ||
| ROIC | N/A |
ROA(3y)-122.53%
ROA(5y)-112.88%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- With a Gross Margin value of 42.40%, NAYA is not doing good in the industry: 66.32% of the companies in the same industry are doing better.
- In the last couple of years the Gross Margin of NAYA has declined.
- NAYA does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 42.4% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-26.71%
GM growth 5Y-15.12%
2. NAYA Health Analysis
2.1 Basic Checks
- NAYA does not have a ROIC to compare to the WACC, probably because it is not profitable.
- Compared to 1 year ago, NAYA has more shares outstanding
- The debt/assets ratio for NAYA has been reduced compared to a year ago.
2.2 Solvency
- NAYA has an Altman-Z score of -6.38. This is a bad value and indicates that NAYA is not financially healthy and even has some risk of bankruptcy.
- The Altman-Z score of NAYA (-6.38) is worse than 73.16% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Altman-Z | -6.38 |
ROIC/WACCN/A
WACC6.25%
2.3 Liquidity
- A Current Ratio of 0.23 indicates that NAYA may have some problems paying its short term obligations.
- NAYA has a Current ratio of 0.23. This is amonst the worse of the industry: NAYA underperforms 95.79% of its industry peers.
- A Quick Ratio of 0.20 indicates that NAYA may have some problems paying its short term obligations.
- NAYA has a worse Quick ratio (0.20) than 96.32% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.23 | ||
| Quick Ratio | 0.2 |
3. NAYA Growth Analysis
3.1 Past
- NAYA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 76.18%, which is quite impressive.
- NAYA shows a strong growth in Revenue. In the last year, the Revenue has grown by 224.37%.
- Measured over the past years, NAYA shows a very strong growth in Revenue. The Revenue has been growing by 43.87% on average per year.
EPS 1Y (TTM)76.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%40.06%
Revenue 1Y (TTM)224.37%
Revenue growth 3Y42.68%
Revenue growth 5Y43.87%
Sales Q2Q%47.75%
3.2 Future
- The Earnings Per Share is expected to decrease by -100.83% on average over the next years. This is quite bad
- NAYA is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 101.26% yearly.
EPS Next Y-3770%
EPS Next 2Y-144.95%
EPS Next 3Y-100.83%
EPS Next 5YN/A
Revenue Next Year125.23%
Revenue Next 2Y57.41%
Revenue Next 3Y39.68%
Revenue Next 5Y101.26%
3.3 Evolution
- The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. NAYA Valuation Analysis
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for NAYA. In the last year negative earnings were reported.
- Also next year NAYA is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- NAYA's earnings are expected to decrease with -100.83% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-144.95%
EPS Next 3Y-100.83%
5. NAYA Dividend Analysis
5.1 Amount
- No dividends for NAYA!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NAYA Fundamentals: All Metrics, Ratios and Statistics
2.2
+0.17 (+8.37%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)04-30 2025-04-30/amc
Earnings (Next)05-13 2025-05-13
Inst Owners2.88%
Inst Owner Change-100%
Ins Owners1.05%
Ins Owner ChangeN/A
Market Cap1.47M
Revenue(TTM)6.23M
Net Income(TTM)-7.47M
Analysts82.86
Price Target6.12 (178.18%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)200%
PT rev (3m)200%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-1100%
EPS NY rev (1m)0%
EPS NY rev (3m)-1100%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-24.84%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.24 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | N/A |
EPS(TTM)-2.96
EYN/A
EPS(NY)-2.45
Fwd EYN/A
FCF(TTM)-4.85
FCFYN/A
OCF(TTM)-4.59
OCFYN/A
SpS9.3
BVpS-0.03
TBVpS-14
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -43.87% | ||
| ROE | N/A | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 42.4% | ||
| FCFM | N/A |
ROA(3y)-122.53%
ROA(5y)-112.88%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-26.71%
GM growth 5Y-15.12%
F-Score3
Asset Turnover0.37
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 21.66% | ||
| Cap/Sales | 2.88% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.23 | ||
| Quick Ratio | 0.2 | ||
| Altman-Z | -6.38 |
F-Score3
WACC6.25%
ROIC/WACCN/A
Cap/Depr(3y)577.95%
Cap/Depr(5y)746.77%
Cap/Sales(3y)8.92%
Cap/Sales(5y)8.57%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)76.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%40.06%
EPS Next Y-3770%
EPS Next 2Y-144.95%
EPS Next 3Y-100.83%
EPS Next 5YN/A
Revenue 1Y (TTM)224.37%
Revenue growth 3Y42.68%
Revenue growth 5Y43.87%
Sales Q2Q%47.75%
Revenue Next Year125.23%
Revenue Next 2Y57.41%
Revenue Next 3Y39.68%
Revenue Next 5Y101.26%
EBIT growth 1Y29.18%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y52.11%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y56.79%
OCF growth 3YN/A
OCF growth 5YN/A
NAYA BIOSCIENCES INC / NAYA Fundamental Analysis FAQ
What is the ChartMill fundamental rating of NAYA BIOSCIENCES INC (NAYA) stock?
ChartMill assigns a fundamental rating of 1 / 10 to NAYA.
What is the valuation status for NAYA stock?
ChartMill assigns a valuation rating of 0 / 10 to NAYA BIOSCIENCES INC (NAYA). This can be considered as Overvalued.
How profitable is NAYA BIOSCIENCES INC (NAYA) stock?
NAYA BIOSCIENCES INC (NAYA) has a profitability rating of 0 / 10.
Can you provide the expected EPS growth for NAYA stock?
The Earnings per Share (EPS) of NAYA BIOSCIENCES INC (NAYA) is expected to decline by -3770% in the next year.